Unicycive Therapeutics, Inc.
UNCY
Nasdaq
Manufacturing
Chemicals
6,63 €
▼
0,02 €
(-0,30%)
Cap. Boursière: 168,84 M
Prix
6,69 €
Cap. Boursière
168,84 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Historique des Prix
Tendances Financières
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 675 000,0 | 675 000,0 | 951 000,0 | — |
| Net Income | -26,56 M | -36,73 M | -30,54 M | -18,06 M | -10,02 M |
| EPS (Diluted) | -1,67 | -0,56 | -1,28 | -1,20 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -29,52 M | -32,12 M | -20,77 M | -18,05 M | -8,98 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 9,12 M | 20,01 M | 12,90 M | 12,44 M | 6,08 M |
| SG&A Expenses | — | — | — | 383 000,0 | 245 000,0 |
| D&A | — | — | — | 428 000,0 | — |
| Interest Expense | 71 000,0 | 71 000,0 | 82 000,0 | 6 000,0 | 628 000,0 |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 49,14 M | 31,67 M | 14,19 M | 2,82 M | 18,74 M |
| Total Liabilities | 18,94 M | 24,24 M | 18,00 M | 3,28 M | 2,26 M |
| Shareholders' Equity | 30,20 M | 7,43 M | -3,81 M | -466 000,0 | 16,48 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 29,20 M | — | — | 455 000,0 | 16,58 M |
| Current Assets | 48,96 M | 30,95 M | 13,40 M | 2,64 M | 18,41 M |
| Current Liabilities | 18,94 M | 24,12 M | 17,53 M | 3,28 M | 2,11 M |
{"event":"ticker_viewed","properties":{"ticker":"UNCY","listing_kind":"stock","pathname":"/stocks/uncy","exchange":"Nasdaq","country":"US"}}